Evidence map›Paper›PMID 26751513›Full record

SynthesisHuman vaccines & immunotherapeutics2016

A systematic review of the efficacy of live attenuated influenza vaccine upon revaccination of children.

Herve Caspard, Terho Heikkinen, Robert B Belshe, Christopher S Ambrose

Open access · bronzeAbstract readSystematic Review
In one paragraph

Synthesis in Human vaccines & immunotherapeutics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Immune responses after live attenuated influenza vaccination.Human vaccines & immunotherapeutics · 2018
    Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Herve Casparda AstraZeneca , Gaithersburg , MD , USA.
Terho Heikkinenb University of Turku and Turku University Hospital , Turku , Finland.
Robert B Belshec St. Louis University Medical Center , St. Louis , MO , USA.
Christopher S Ambrosec St. Louis University Medical Center , St. Louis , MO , USA.
University Medical Center · USAstraZeneca (United States) · USUniversity of Turku · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Four randomized, double-blind, placebo-controlled studies in 6090 children that investigated the efficacy of live attenuated influenza vaccine (LAIV) upon revaccination of children against laboratory-confirmed cases of influenza in consecutive seasons were reviewed. The efficacy in season 2 of LAIV administered over 2 consecutive seasons was 86.7% (95 % CI: 76.8%, 92.4%) against strains antigenically similar to those contained in the vaccine. The additional efficacy of LAIV administered in season 2 compared to LAIV recipients in season 1 only was 58.4% (28.3%, 75.9%). LAIV administered over 2 consecutive seasons also was more efficacious than was LAIV administered in season 2 only (relative efficacy: 53.9% [17.4%, 74.3%]). Residual efficacy of LAIV administered in season 1 only compared to placebo administered in two consecutive seasons was 56.4% (37.0%, 69.8%). This review did not find any evidence of decreasing efficacy of LAIV when administered during 2 consecutive seasons.

Indexed as

Immunization, SecondaryChildChild, PreschoolHumansInfantInfluenza VaccinesPlacebosRandomized Controlled Trials as TopicTreatment OutcomeVaccines, AttenuatedInfluenza VaccinesPlacebosVaccines, Attenuatedchildrenefficacylive attenuated influenza vaccinerepeat vaccinationrevaccination

Identifiers

PMID26751513
PMCPMC4964816
OpenAlexW2235773355

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.